HopeStage
Back to all studies
CompletedNCT00982020

Olanzapine with standard or intensive weight support for teens with schizophrenia or bipolarity

About this title

Study in Adolescents With Schizophrenia or Bipolar Disorder

Read the official source — NCT00982020
Medication studyAges 13–17Multiple countries
The study in practice

Understand this study

Who was this study for?

Listed age limits: 13 years to 17 years.

Listed locations
Lauderhill and 13 more locationsSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateSeptember 2009
Recruitment status
Completed
Enrollment listed in the registry
203
Sponsor
Eli Lilly and Company
Sponsor type
Other organization
Study type
Drug
Intervention type
Behavioural, Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States, Poland, Russia
Age range
From 13 Years to 17 Years
Official registry ID
NCT00982020
Official title
Show the full official title

A Long-Term, Open-Label, Safety Study of Oral Olanzapine in Adolescents With Bipolar I Disorder (Manic or Mixed Episodes) or Schizophrenia

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Lauderhill, United States · Bloomfield Hills, United States · St Louis, United States

12 more locations
  • Bellevue, United States
  • Poznan, Poland
  • Torun, Poland
  • Wroclaw, Poland
  • Caguas, Puerto Rico
  • San Juan, Puerto Rico
  • Lipetsk, Russia
  • Moscow, Russia
  • Petrozavodsk, Russia
  • Saint Petersburg, Russia
  • Saratov, Russia
  • Russia

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Eli Lilly and Company.

Did this study involve medication?

Yes. The study involved medication, including Olanzapine.

Who was this study for?

Listed age limits: 13 years to 17 years.

Want to explore more studies?

Explore studies